Works matching IS 03682811 AND DT 2019 AND VI 49 AND IP 8

Results: 18

Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy achieved the equivalent survival compared with concurrent chemoradiotherapy in cervical cancer patients with intermediate-risk.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 714, doi. 10.1093/jjco/hyz057

By:

Yu, Hao;
Zhang, Linlin;
Li, Dapeng;
Liu, Naifu;
Yin, Yueju;
Zhang, Lu;
Yuan, Lingqin;
Liu, Ming;
Sheng, Xiugui

Publication type:

Article

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 772, doi. 10.1093/jjco/hyz054

By:

Kume, Haruki;
Homma, Yukio;
Shinohara, Nobuo;
Obara, Wataru;
Kondo, Tsunenori;
Kimura, Go;
Fujimoto, Hiroyuki;
Nonomura, Norio;
Hongo, Fumiya;
Sugiyama, Takayuki;
Takahashi, Masayuki;
Kanayama, Hiro-omi;
Fukumori, Tomoharu;
Eto, Masatoshi

Publication type:

Article

Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 749, doi. 10.1093/jjco/hyz064

By:

Miyanaga, Akihiko;
Kubota, Kaoru;
Hosomi, Yukio;
Okuma, Yusuke;
Minato, Koichi;
Fujimoto, Sakae;
Okamoto, Hiroaki;
Satouchi, Miyako;
Isobe, Hiroshi;
Aono, Hiromi;
Takiguchi, Yuichi;
Gemma, Akihiko;
Group, for The Tokyo Cooperative Oncology

Publication type:

Article

A preliminary study of the effectiveness of cancer communication skills training for interdisciplinary staff.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 734, doi. 10.1093/jjco/hyz065

By:

Hsu, Tsui-Hsia;
Li, I-Chuan;
Fang, Chun-Kai;
Tang, Woung-Ru;
Lin, Chih-Tsun

Publication type:

Article

A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 743, doi. 10.1093/jjco/hyz063

By:

Iehara, Tomoko;
Yagyu, Shigeki;
Gotoh, Takahiro;
Ouchi, Kazutaka;
Yoshida, Hideki;
Miyachi, Mitsuru;
Kikuchi, Ken;
Sugimoto, Tohru;
Hosoi, Hajime

Publication type:

Article

Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculator.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 727, doi. 10.1093/jjco/hyz050

By:

Miyamoto, Kenichi;
Nakamura, Kenichi;
Mizusawa, Junki;
Balincourt, Christine de;
Fukuda, Haruhiko

Publication type:

Article

Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 780, doi. 10.1093/jjco/hyz067

By:

Kaneko, Go;
Shirotake, Suguru;
Nishimoto, Koshiro;
Miyazaki, Yasumasa;
Ito, Keiichi;
Ito, Yujiro;
Hagiwara, Masayuki;
Kanao, Kent;
Nakagawa, Ken;
Momma, Tetsuo;
Asano, Tomohiko;
Tanaka, Nobuyuki;
Mizuno, Ryuichi;
Oya, Mototsugu;
Oyama, Masafumi

Publication type:

Article

An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 789, doi. 10.1093/jjco/hyz085

By:

Lee, Jung-Yun;
Yi, Ju Yeon;
Kim, Hyun-Soo;
Lim, June;
Kim, Sunghoon;
Nam, Byoung Ho;
Kim, Hee Seung;
Kim, Jae Weon;
Choi, Chel Hun;
Kim, Byoung-Gie;
investigators, on behalf of KGOG

Publication type:

Article

Issues associated with medical tourism for cancer care in Japan.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 708, doi. 10.1093/jjco/hyz061

By:

Awano, Nobuyasu;
Takamoto, Takeshi;
Kawakami, Junko;
Genda, Atsuko;
Ninomiya, Akiko;
Ikeda, Misato;
Matsuno, Fumie;
Izumo, Takehiro;
Kunitoh, Hideo

Publication type:

Article

Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutation.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 786, doi. 10.1093/jjco/hyz086

By:

Iwamoto, Yoshitaka;
Ichihara, Eiki;
Hara, Naofumi;
Nakasuka, Takamasa;
Ando, Chihiro;
Umeno, Takahiro;
Hirabae, Atsuko;
Maeda, Yoshinobu;
Kiura, Katsuyuki

Publication type:

Article

Immunomodulatory drugs in the treatment of multiple myeloma.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 695, doi. 10.1093/jjco/hyz083

By:

Abe, Yu;
Ishida, Tadao

Publication type:

Article

Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 766, doi. 10.1093/jjco/hyz051

By:

Kosaka, Takeo;
Uemura, Hiroji;
Sumitomo, Makoto;
Harada, Kenichi;
Sugimoto, Mikio;
Hayashi, Narihiko;
Yoshimura, Kazuhiro;
Fukasawa, Satoshi;
Ecstein-Fraisse, Evelyne;
Sunaga, Yoshinori;
Oya, Mototsugu

Publication type:

Article

Incidence rates of esophageal cancer in the world from the Cancer Incidence in Five Continents XI.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 1, doi. 10.1093/jjco/hyz114

By:

Matsuoka, Junko;
Hori, Megumi

Publication type:

Article

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 762, doi. 10.1093/jjco/hyz066

By:

Watanabe, Hiromi;
Kubo, Toshio;
Ninomiya, Kiichiro;
Kudo, Kenichiro;
Minami, Daisuke;
Murakami, Etsuko;
Ochi, Nobuaki;
Ninomiya, Takashi;
Harada, Daijiro;
Yasugi, Masayuki;
Ichihara, Eiki;
Ohashi, Kadoaki;
Fujiwara, Keiichi;
Hotta, Katsuyuki;
Tabata, Masahiro;
Maeda, Yoshinobu;
Kiura, Katsuyuki

Publication type:

Article

Mesenchymal–epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinoma.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 755, doi. 10.1093/jjco/hyz060

By:

Ando, Ryota;
Fujino, Masahiko;
Kominami-Kiriyama, Ayami;
Ito, Ai;
Koide, Tomomi;
Ito, Masafumi

Publication type:

Article

Nivolumab-induced autoimmune encephalitis in an anti-neuronal autoantibody-positive patient.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 793, doi. 10.1093/jjco/hyz087

By:

Shibaki, Ryota;
Murakami, Shuji;
Oki, Koichi;
Ohe, Yuichiro

Publication type:

Article

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 703, doi. 10.1093/jjco/hyz090

By:

Matsumoto, Koji;
Nishimura, Meiko;
Onoe, Takuma;
Sakai, Hideki;
Urakawa, Yusaku;
Onda, Takashi;
Yaegashi, Nobuo

Publication type:

Article

The combination of histone deacetylase and p53 expressions and histological subtype has prognostic implication in uterine leiomyosarcoma.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 719, doi. 10.1093/jjco/hyz059

By:

Baek, Min-Hyun;
Park, Jeong-Yeol;
Park, Yangsoon;
Kim, Kyu-Rae;
Kim, Dae-Yeon;
Suh, Dae-Shik;
Kim, Jong-Hyeok;
Kim, Yong-Man;
Kim, Young-Tak;
Nam, Joo-Hyun

Publication type:

Article